ALFA Finder| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 26.8 | 20.7 | 34.0 |
| Other income | -0.0 | 0.1 | -0.3 |
| Total income | 26.8 | 20.8 | 33.7 |
| Profit before exceptional items & tax | 2.4 | 0.5 | 0.9 |
| Profit before tax | 2.4 | 0.5 | 0.9 |
| Net profit | 2.4 | 0.4 | 1.0 |
| Operating margin | 9.0% | 2.4% | 2.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +140.00% |
|---|---|
| Net profit, quarter on quarter | +500.00% |
| Revenue, year on year | -21.20% |
| Operating profit, year on year | +100.00% |
| Operating profit, quarter on quarter | +500.00% |
BSE results filing, NSE: LAURLOR. Figures extracted from the filing.
Kimia Biosciences Ltd: key numbers
- Share price
- ₹32.50
- Market cap
- ₹153.8 Cr
- Revenue (annual)
- ₹114.9 Cr
- Net profit (annual)
- ₹7.43 Cr
- P/E (TTM)
- 21.4×Sector 43.7×
- Promoter holding
- 74.94%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kimia Biosciences Ltd
All →Kimia Biosciences Board Meeting Date
Kimia Biosciences Limited has scheduled a board meeting for November 13, 2026. The board will consider and approve the un-audited standalone financial results for the second quarter.
Kimia Biosciences Other Announcement
Kimia Biosciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Kimia Biosciences Management Change
Kimia Biosciences Limited announced the re-appointment of Mr. Sameer Goel as Executive Director and changes in designation for three other directors on the board.
Kimia Biosciences Annual General Meeting
Kimia Biosciences Ltd filed the proceedings of its 33rd Annual General Meeting held on September 28, 2026, where shareholders considered various ordinary and special resolutions.
Kimia Biosciences Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended March 31, 2026.
Kimia Biosciences Annual General Meeting
Kimia Biosciences Limited has submitted its notice for the 33rd Annual General Meeting scheduled for September 28, 2026, along with the Annual Report for FY 2025-26.